JOHNATHAN PIERSON: Open Payments
NPI 1548376320 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,938 in 112 payments from 15 companies in 2025. Trend: 2023 $1,038 · 2024 $1,522 · 2025 $1,938
Food & beverage: $1,853Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $488 |
| Janssen Biotech, Inc. | 26 | $337 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $298 |
| Amgen Inc. | 10 | $163 |
| GENZYME CORPORATION | 7 | $147 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Organon LLC | 5 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| Lilly USA, LLC | 4 | $70 |
| Galderma Laboratories, L.P. | 3 | $54 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, OTEZLA, ILUMYA, Winlevi, COSENTYX.
Industry payments across VA — which companies pay providers there.
